Preparation, characterization and anticancer therapeutic efficacy of cisplatin-loaded niosomes

Journal of Microencapsulation

Volumn 30, Issue 3, 2013, Pages 237-244

  Yang, Hong ^a   Deng, Anping ^a   Zhang, Jingqing ^b   Wang, Jian ^c   Lu, Bin ^d  

^a SOOCHOW UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c SICHUAN CANCER HOSPITAL   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Body weight change; Cisplatin; Inhibition of tumour growth; Niosomes; Sustained release profile; Tumour metastasis

Indexed keywords

CHOLESTEROL; CISPLATIN; NIOSOME; SORBITAN PALMITATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG LOADING; DRUG RELEASE; DRUG SYNTHESIS; ENTRAPMENT EFFICIENCY; EXPERIMENTAL RABBIT; INGUINAL LYMPH NODE; LIVER METASTASIS; LYMPH NODE METASTASIS; LYOPHILISATE; MORTALITY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; WEIGHT CHANGE; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG CARRIERS; MICROSCOPY, ELECTRON, TRANSMISSION; RABBITS; SARCOMA, EXPERIMENTAL;

EID: 84875826202     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.717116     Document Type: Article

References (23)

1. Bontha S, Kabanov AV, Bronich TK. Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J Control Release, 2006;114: 163-74. (Pubitemid 44308502)
2. Chen Y, Yang H, Lu B, Li M, Zong TL. Preparation of lung-targeting cisdichlorodiammineplatinum niosomes and evaluation of their characteristics in vitro. J West China Pharm Sci, 2008;23(2): 129-32.
3. Grunberg E, Chassan JB, Hines LR. Relationship between change in body weight and weight of tumor: A contrast between tumor systems in mice. Chemotherapy, 1965;10(5): 269-76.
4. Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNC prostate cancer cells. Eur J Pharm Biopharm, 2007;67: 1-8. (Pubitemid 46991325)
5. Gupta PK, Hung CT, Perrier DG. Quantization of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci, 1987;76: 141-5. (Pubitemid 17043680)
6. Hao YM, Zhao FL, Li N, Yang YH, Li KA. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm, 2002;244: 73-80. (Pubitemid 35245447)
7. Huo D, Deng S, Li L, Ji J. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm, 2005;289: 63-7. (Pubitemid 40093541)
8. Lawrence MJ. Formation, characterization and stability of nonionic surfactant vesicles. STP Pharm Sci, 1996;6(1): 49-60.
9. Liu Y, Gao WG, Liu WP. Study on the photostability of cisplatin injection. Chin Pharm Affairs, 2005;19(10): 613-14.
10. Lu B. 2005. New techniques and new dosage forms of drugs. 2nd ed. Beijing: Publishers of People's Health. pp. 55-65.
11. Lu B, Xiong SB, Yang H, Yin XD, Chao RB. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases II: Tissue distribution and pharmacokinetics. Int J Pharm, 2006;307(2): 175-81. (Pubitemid 41820411)
12. Lu B, Zhang ZQ. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: Their preparation, release behavior and therapeutic efficiency against colonic cancer. J Pharm Sci, 2006;95(12): 2619-30. (Pubitemid 46093170)
13. Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: A comparative study between liposomes and niosomes. J Microencapsul, 2008;25(7): 499-512.
14. Ozer AY, Boustra JA. A novel drug delivery system: Non-ionic surfactant vesicles. Eur J Pharm Biopharm, 1991;37: 75-9.
15. Peleg-Shulman T, Gibson D, Cohen R, Abra R, Barenholz Y. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. Biochim Biophys Acta, 2001;1510: 278-91. (Pubitemid 32149903)
16. Pi FM, Tu XD, Wu Y. Preparation of ATP-2Na loaded liposome and its effect on tissues energy state in myocardial ischemic mice. Acta Pharm Sin, 2010;45(10): 1322-6.
17. Rentel CO, Bouwstra JA, Naisbett B, Junginger HE. Niosomes as a novel peroral vaccine delivery system. Int J Pharm, 1999;186: 161-7. (Pubitemid 29459043)
18. Song SL, Liu JJ, Huang G, Wang ZH, Song YY, Sun XG, Chen T. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model. J Nucl Med, 2008;49(2): 303-9. (Pubitemid 351225670)
19. Sun Y, 2007. Handbook of anticancer drugs. Beijing: Medical Publishers of Beijing University. pp. 13-15.
20. Townsend DM, Hanigan MH. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J Pharmacol Exp Ther, 2002; 300: 142-8. (Pubitemid 34028520)
21. Wang ZM, Ren ZG, Ye D. Metastatic characteristics of rabbit liver VX2 cancer model. Cancer, 2006;26(1): 1057-8.
22. Wang X, Zhang JC, Zhu GY, 2001. Elementary oncology and outline of therapeutics. Shanghai: Publishing House of 2nd Medical University of PLA. pp. 243-5.
23. Zhang M, Hou SX, Gong T, Chen YH, Liao GT. Derivative assay of bovine serum albumin microspheres loaded cisplatin for pulmonary targeting. China J Pharm, 1994;29(6): 355-7. (Pubitemid 24256202)